Intrahepatic Cholangiocarcinoma Clinical Trials in Hangzhou, Zhejiang
4 recruitingHangzhou, Zhejiang, China
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma
Advanced Intrahepatic Cholangiocarcinoma
Zhejiang University30 enrolled1 locationNCT06956716
Recruiting
Phase 2
GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence
Intrahepatic Cholangiocarcinoma
Zhejiang Cancer Hospital20 enrolled2 locationsNCT05557578
Recruiting
Phase 2
Clinical Study of VG161 in Advanced Intrahepatic Cholangiocarcinoma
Advanced Intrahepatic Cholangiocarcinoma
CNBG-Virogin Biotech (Shanghai) Ltd.33 enrolled1 locationNCT06746480
Recruiting
Phase 2
A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma (Icc)
Beijing InnoCare Pharma Tech Co., Ltd.70 enrolled44 locationsNCT05678270